The Center for Black Empowerment is calling on the FDA to approve E-cigarettes

According to a press release, the Center for Black Empowerment (CBE) is calling on the U.S. Food and Drug Administration and the Center for Tobacco Products to broadly approve a full line of nicotine e-cigarettes(hnb heatsticks supplier). This is an important step toward closing the significant harm reduction and health equity gaps created by FDA's current tobacco policies. The Center for Black Empowerment said the approval of e-cigarette(tobacco heatsticks manufacturer) products would benefit black and gender minority LGBTQ+ populations, who are disproportionately affected by the negative health effects of smoking, including cancer.


As the CBE calls for broader regulatory approval of e-cigarettes(tabak heatsticks producer), including flavored e-cigarette products, it has released an econometrics report that for the first time quantifies the benefits of switching from smoking to e-cigarettes in terms of lives saved, GDP benefits and healthcare savings.


The report was written by Robert J. Shapiro, a former undersecretary for economic affairs at the Commerce Department and an adviser to former President Clinton, former President Obama and former President Biden. Shapiro's report found that from 2010 to 2022, switching from smoking to e-cigarettes saved 113,000 lives, preserved $137 billion in GDP, and saved $39 billion in health care costs, while the popularity of e-cigarettes reduced the number of smokers in the United States by 6.1 million during the same period.


"Advocating for meaningful harm reduction initiatives for black and LGBTQ+ communities has been an elusive but essential aspect of effective public health advocacy for decades," said Earl Fowlkes, CBE president and CEO. "If the Biden administration and the FDA are serious about health equity and harm reduction, especially when it comes to the president's cancer moonshot, the science is clear: widespread approval of flavored e-cigarette products will save black and LGBTQ+ lives, reduce smoking, and make meaningful progress in reducing preventable cancer rates in the United States, especially among the most vulnerable."


The report also reviewed the existing academic and medical literature on e-cigarettes and smoking to examine and validate the overwhelming scientific evidence that e-cigarettes carry significantly lower risks than cigarettes and can help individuals successfully reduce smoking or quit altogether.


"The single most effective way to help people quit smoking is to encourage them to switch to e-cigarettes, which don't kill anyone every year," Shapiro said.


"The Center for Tobacco Products needs to be honest with American smokers - especially those in black and LGBTQ+ communities who smoke at disproportionately high rates - and aggressively communicate the tremendous health benefits of switching from smoking to e-cigarettes," Shapiro added. Future FDA policy on tobacco and nicotine products should be based on mature scientific evidence about the relative risks of e-cigarettes versus cigarettes and the utility of people using e-cigarettes to quit or reduce smoking."

The report also directly examines a major concern of e-cigarette critics, the so-called "teen vaping epidemic," which is allegedly being caused by the FDA's formal approval of e-cigarette products. Shapiro continued, "The so-called 'youth vaping crisis' narrative in the media has been around for some time and, strangely, has been unfounded in the FDA's public health dialogue." "The CDC's own data shows that teen e-cigarette use has declined substantially in recent years, to 2014 levels, well below the 2019 peak, and that most young people who vaped were irregularly or sporadically, not dependent on nicotine."


"The FDA and the Center for Tobacco Products have an obligation to follow the science, support harm reduction and health equity, and advance, not delay, President Biden's cancer moonshot, and the FDA must acknowledge the evidence-based benefits of switching from smoking to e-cigarettes and actively educate black, LGBTQ+, and other smokers about these benefits," Fox concluded. The failure to approve a wide range of e-cigarette products is an abdication of the FDA's public health responsibility to black and LGBTQ+ individuals across the country who are desperate to find a way to quit smoking that actually works."